BiotechTube
Home/BrainStorm Cell Therapeutics/Bob Dagher
BD

Bob Dagher

Executive Vice President, Chief Medical Officer, Head of Medical

BrainStorm Cell Therapeutics

Therapeutic Areas

Neurodegenerative DiseasesAmyotrophic Lateral Sclerosis

BrainStorm Cell Therapeutics Pipeline

DrugIndicationPhase
NurOwn® (debamestrocel)Amyotrophic Lateral Sclerosis (ALS)Phase 3b
NurOwn® PlatformProgressive Multiple Sclerosis (MS)Phase 2

Leadership Team at BrainStorm Cell Therapeutics

CL
Chaim Lebovits
President and Chief Executive Officer
RK
Ralph Kern
Chief Operating Officer and Chief Medical Officer
KT
Kirk Taylor
Executive Vice President, Chief Medical Officer
View full BrainStorm Cell Therapeutics profile